{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:20Z","timestamp":1786933460645,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00858-5","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:45:26Z","timestamp":1780980326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Piceatannol attenuates thoracic aortic aneurysm progression by targeting STK33"],"prefix":"10.1186","volume":"21","author":[{"given":"Yubo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"1","key":"858_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41572-025-00617-2","volume":"11","author":"T Berger","year":"2025","unstructured":"Berger T, Dumfarth J, Kreibich M, Minatoya K, Ziganshin BA, Czerny M. Thoracic aortic aneurysm. Nat Rev Dis Primers. 2025;11(1):34. https:\/\/doi.org\/10.1038\/s41572-025-00617-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"858_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0003-4975(01)03236-2","volume":"73","author":"RR Davies","year":"2002","unstructured":"Davies RR, Goldstein LJ, Coady MA, Tittle SL, Rizzo JA, Kopf GS, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. The Ann Thorac Surg. 2002;73(1):17\u201328; discussion -8. https:\/\/doi.org\/10.1016\/S0003-4975(01)03236-2.","journal-title":"The Ann Thorac Surg"},{"issue":"3","key":"858_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0022-5223(97)70360-X","volume":"113","author":"MA Coady","year":"1997","unstructured":"Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? The J Thorac Cardiovasc Surg. 1997;113(3):476\u201391; discussion 89-91. https:\/\/doi.org\/10.1016\/S0022-5223(97)70360-X.","journal-title":"The J Thorac Cardiovasc Surg"},{"issue":"36","key":"858_CR4","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700. https:\/\/doi.org\/10.1093\/eurheartj\/ehae179.","journal-title":"Eur Heart J"},{"issue":"1","key":"858_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.athoracsur.2024.01.021","volume":"118","author":"M Czerny","year":"2024","unstructured":"Czerny M, Grabenw\u00f6ger M, Berger T, Aboyans V, Della Corte A, Chen EP, et al. EACTS\/STS guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. The Ann Thorac Surg. 2024;118(1):5\u2013115. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.01.021.","journal-title":"The Ann Thorac Surg"},{"issue":"7708","key":"858_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73\u201379. https:\/\/doi.org\/10.1038\/s41586-018-0175-2.","journal-title":"Nature"},{"issue":"12","key":"858_CR7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00978-w.","journal-title":"Nat Genet"},{"issue":"11","key":"858_CR8","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol: JASN. 2016;27(11):3253\u201365. https:\/\/doi.org\/10.1681\/ASN.2016010098.","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"9822","key":"858_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"DI Swerdlow","year":"2012","unstructured":"Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (Lond, Engl). 2012;379(9822):1214\u201324.","journal-title":"Lancet (Lond, Engl)"},{"issue":"1","key":"858_CR10","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, Noyce AJ, et al. Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat Commun. 2021;12(1):7342. https:\/\/doi.org\/10.1038\/s41467-021-26280-1.","journal-title":"Nat Commun"},{"issue":"4","key":"858_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","volume":"27","author":"L Gaziano","year":"2021","unstructured":"Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med. 2021;27(4):668\u201376. https:\/\/doi.org\/10.1038\/s41591-021-01310-z.","journal-title":"Nat Med"},{"issue":"1","key":"858_CR12","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255. https:\/\/doi.org\/10.1038\/s41467-020-16969-0.","journal-title":"Nat Commun"},{"issue":"5","key":"858_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u201387. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"key":"858_CR14","doi-asserted-by":"publisher","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Science translational medicine. 2017. Sci Transl Med. 2017;9(383). https:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","DOI":"10.1126\/scitranslmed.aag1166"},{"issue":"11","key":"858_CR15","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","volume":"54","author":"G Sveinbjornsson","year":"2022","unstructured":"Sveinbjornsson G, Ulfarsson MO, Thorolfsdottir RB, Jonsson BA, Einarsson E, Gunnlaugsson G, et al. Multiomics study of nonalcoholic fatty liver disease. Nat Genet. 2022;54(11):1652\u201363. https:\/\/doi.org\/10.1038\/s41588-022-01199-5.","journal-title":"Nat Genet"},{"issue":"1","key":"858_CR16","doi-asserted-by":"publisher","first-page":"9302","DOI":"10.1038\/s41467-024-53621-7","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu X, Ying H, Yang Q, Yang Q, Liu H, Ding Y, et al. Transcriptome-wide Mendelian randomization during CD4+ T cell activation reveals immune-related drug targets for cardiometabolic diseases. Nat Commun. 2024;15(1):9302. https:\/\/doi.org\/10.1038\/s41467-024-53621-7.","journal-title":"Nat Commun"},{"issue":"1","key":"858_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-021-01299-2","volume":"20","author":"MA Elhadad","year":"2021","unstructured":"Elhadad MA, Wilson R, Zaghlool SB, Huth C, Gieger C, Grallert H, et al. Metabolic syndrome and the plasma proteome: from association to causation. Cardiovasc Diabetol. 2021;20(1):111. https:\/\/doi.org\/10.1186\/s12933-021-01299-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"858_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41598-017-19096-x","volume":"8","author":"PT Tseng","year":"2018","unstructured":"Tseng PT, Cheng YS, Yen CF, Chen YW, Stubbs B, Whiteley P, et al. Peripheral iron levels in children with attention-deficit hyperactivity disorder: a systematic review and meta-analysis. Sci Rep. 2018;8(1):788. https:\/\/doi.org\/10.1038\/s41598-017-19096-x.","journal-title":"Sci Rep"},{"issue":"2","key":"858_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"858_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u201398. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"issue":"1","key":"858_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinf. 2013;14(1):128. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinf"},{"issue":"3","key":"858_CR22","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98(3):1627\u2013738. https:\/\/doi.org\/10.1152\/physrev.00038.2017.","journal-title":"Physiol Rev"},{"issue":"2","key":"858_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/ijms25020901","volume":"25","author":"Y Wang","year":"2024","unstructured":"Wang Y, Panicker IS, Anesi J, Sargisson O, Atchison B, Habenicht AJR. Animal models, pathogenesis, and potential treatment of thoracic aortic aneurysm. IJMS. 2024;25(2):901. https:\/\/doi.org\/10.3390\/ijms25020901.","journal-title":"IJMS"},{"issue":"19","key":"858_CR24","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/01.CIR.0000038109.84500.1E","volume":"106","author":"JM Maki","year":"2002","unstructured":"Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, et al. Inactivation of the lysyl oxidase gene lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation. 2002;106(19):2503\u201309. https:\/\/doi.org\/10.1161\/01.CIR.0000038109.84500.1E.","journal-title":"Circulation"},{"key":"858_CR25","doi-asserted-by":"publisher","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412.","DOI":"10.1371\/journal.pbio.1000412"},{"issue":"3","key":"858_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00109-023-02284-w","volume":"101","author":"Z Gong","year":"2023","unstructured":"Gong Z, Huang J, Wang D, Yang S, Ma Z, Fu Y, et al. ADAMTS-7 deficiency attenuates thoracic aortic aneurysm and dissection in mice. J Mol Med. 2023;101(3):237\u201348. https:\/\/doi.org\/10.1007\/s00109-023-02284-w.","journal-title":"J Mol Med"},{"key":"858_CR27","doi-asserted-by":"publisher","first-page":"109107","DOI":"10.1016\/j.intimp.2022.109107","volume":"111","author":"Z Tieyuan","year":"2022","unstructured":"Tieyuan Z, Ying Z, Xinghua Z, Huimin W, Huagang L. Piceatannol-mediated JAK2\/STAT3 signaling pathway inhibition contributes to the alleviation of oxidative injury and collagen synthesis during pulmonary fibrosis. Int Immunopharmacol. 2022;111:109107. https:\/\/doi.org\/10.1016\/j.intimp.2022.109107.","journal-title":"Int Immunopharmacol"},{"key":"858_CR28","doi-asserted-by":"publisher","first-page":"149598","DOI":"10.1016\/j.bbrc.2024.149598","volume":"700","author":"M Zhu","year":"2024","unstructured":"Zhu M, Zhao T, Zha B, Zhang G, Qian W, Wang X, et al. Piceatannol protects against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis via nrf-2 signaling-mediated iron metabolism. Biochem Bioph Res Co. 2024;700:149598. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149598.","journal-title":"Biochem Bioph Res Co"},{"issue":"12","key":"858_CR29","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/CIRCRESAHA.117.311450","volume":"121","author":"G Zhao","year":"2017","unstructured":"Zhao G, Fu Y, Cai Z, Yu F, Gong Z, Dai R, et al. Unspliced XBP1 confers VSMC homeostasis and prevents aortic aneurysm formation via FoxO4 interaction. Circ Res. 2017;121(12):1331\u201345. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311450.","journal-title":"Circ Res"},{"issue":"18","key":"858_CR30","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. DSigDB: drug signatures database for gene set analysis. Bioinf (Oxford, Engl). 2015;31(18):3069\u201371. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313.","journal-title":"Bioinf (Oxford, Engl)"},{"issue":"2","key":"858_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0163-7258(97)00089-2","volume":"77","author":"PK Chiang","year":"1998","unstructured":"Chiang PK. Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. Pharmacol Ther. 1998;77(2):115\u201334. https:\/\/doi.org\/10.1016\/S0163-7258(97)00089-2.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"858_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12956","volume":"1363","author":"SJ Mentch","year":"2016","unstructured":"Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Ann New Y Acad Sci. 2016;1363(1):91\u201398. https:\/\/doi.org\/10.1111\/nyas.12956.","journal-title":"Ann New Y Acad Sci"},{"issue":"3","key":"858_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1527-3458.2007.00020.x","volume":"13","author":"MJ Bonif\u00e1cio","year":"2007","unstructured":"Bonif\u00e1cio MJ, Palma PN, Almeida L, Soares-da-Silva P. Catechol- O -methyltransferase and its inhibitors in Parkinson\u2019s disease. CNS Drug Rev. 2007;13(3):352\u201379. https:\/\/doi.org\/10.1111\/j.1527-3458.2007.00020.x.","journal-title":"CNS Drug Rev"},{"issue":"11","key":"858_CR34","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/ptr.5185","volume":"28","author":"YL Tang","year":"2014","unstructured":"Tang YL, Chan SW. A review of the pharmacological effects of piceatannol on cardiovascular diseases. Phytotherapy Res: PTR. 2014;28(11):1581\u201388. https:\/\/doi.org\/10.1002\/ptr.5185.","journal-title":"Phytotherapy Res: PTR"},{"issue":"22","key":"858_CR35","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.3390\/molecules25225343","volume":"25","author":"M Otr\u0119ba","year":"2020","unstructured":"Otr\u0119ba M, Ko\u015bmider L, Stojko J, Rzepecka-Stojko A. Cardioprotective activity of selected polyphenols based on epithelial and aortic cell lines. A review. Mol (Basel, Switz). 2020;25(22):5343. https:\/\/doi.org\/10.3390\/molecules25225343.","journal-title":"Mol (Basel, Switz)"},{"issue":"2","key":"858_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/biof.2009","volume":"50","author":"H Gandhi","year":"2024","unstructured":"Gandhi H, Mahant S, Sharma AK, Kumar D, Dua K, Chellappan DK, et al. Exploring the therapeutic potential of naturally occurring piceatannol in non-communicable diseases. BioFactors (Oxford, Engl). 2024;50(2):232\u201349. https:\/\/doi.org\/10.1002\/biof.2009.","journal-title":"BioFactors (Oxford, Engl)"},{"key":"858_CR37","doi-asserted-by":"publisher","first-page":"108754","DOI":"10.1016\/j.cbi.2019.108754","volume":"310","author":"H Li","year":"2019","unstructured":"Li H, Shi Y, Wang X, Li P, Zhang S, Wu T, et al. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2\/HO-1 and NF-\u03baB pathways in diabetic cardiomyopathy. Chemico-Biol Interact. 2019;310:108754. https:\/\/doi.org\/10.1016\/j.cbi.2019.108754.","journal-title":"Chemico-Biol Interact"},{"issue":"3","key":"858_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1124\/jpet.120.000096","volume":"376","author":"R Hosoda","year":"2021","unstructured":"Hosoda R, Hamada H, Uesugi D, Iwahara N, Nojima I, Horio Y, et al. Different antioxidative and antiapoptotic effects of piceatannol and resveratrol. J Pharmacol Exp Ther. 2021;376(3):385\u201396. https:\/\/doi.org\/10.1124\/jpet.120.000096.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"858_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3892\/ijmm.2013.1261","volume":"31","author":"A Woo","year":"2013","unstructured":"Woo A, Shin W, Cuong TD, Min B, Lee JH, Jeon BH, et al. Arginase inhibition by piceatannol-3\u2032-O-\u03b2-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet. Int J Mol Med. 2013;31(4):803\u201310. https:\/\/doi.org\/10.3892\/ijmm.2013.1261.","journal-title":"Int J Mol Med"},{"issue":"16","key":"858_CR40","first-page":"3125","volume":"19","author":"Y Son","year":"2015","unstructured":"Son Y, Lee JH, Cheong YK, Jung HC, Jeong SO, Park SH, et al. Piceatannol, a natural hydroxylated analog of resveratrol, promotes nitric oxide release through phosphorylation of endothelial nitric oxide synthase in human endothelial cells. Eur Rev Med Pharmacol Sci. 2015;19(16):3125\u201332.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"858_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/10715762.2010.527337","volume":"45","author":"M Frombaum","year":"2011","unstructured":"Frombaum M, Therond P, Djelidi R, Beaudeux JL, Bonnefont-Rousselot D, Borderie D. Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress. Free Radic Res. 2011;45(3):293\u2013302. https:\/\/doi.org\/10.3109\/10715762.2010.527337.","journal-title":"Free Radic Res"},{"issue":"7","key":"858_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.tiv.2009.07.023","volume":"23","author":"B Lee","year":"2009","unstructured":"Lee B, Lee EJ, Kim DI, Park SK, Kim WJ, Moon SK. Inhibition of proliferation and migration by piceatannol in vascular smooth muscle cells. Toxicol Vitro: Int J Published Assoc BIBRA. 2009;23(7):1284\u201391. https:\/\/doi.org\/10.1016\/j.tiv.2009.07.023.","journal-title":"Toxicol Vitro: Int J Published Assoc BIBRA"},{"issue":"5","key":"858_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/life14050589","volume":"14","author":"K Tanaka","year":"2024","unstructured":"Tanaka K, Kawakami S, Mori S, Yamaguchi T, Saito E, Setoguchi Y, et al. Piceatannol upregulates SIRT1 expression in skeletal muscle cells and in human whole blood: In Vitro assay and a randomized, Double-blind, placebo-controlled, parallel-group comparison trial. Life (Basel, Switz). 2024;14(5):589. https:\/\/doi.org\/10.3390\/life14050589.","journal-title":"Life (Basel, Switz)"},{"issue":"1","key":"858_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/gutjnl-2014-307545","volume":"65","author":"T Yang","year":"2016","unstructured":"Yang T, Song B, Zhang J, Yang GS, Zhang H, Yu WF, et al. STK33 promotes hepatocellular carcinoma through binding to c-Myc. Gut. 2016;65(1):124\u201333. https:\/\/doi.org\/10.1136\/gutjnl-2014-307545.","journal-title":"Gut"},{"issue":"12","key":"858_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.123.063332","volume":"148","author":"A Chakraborty","year":"2023","unstructured":"Chakraborty A, Li Y, Zhang C, Li Y, Rebello KR, Li S, et al. Epigenetic induction of smooth muscle cell phenotypic alterations in aortic aneurysms and dissections. Circulation. 2023;148(12):959\u201377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.063332.","journal-title":"Circulation"},{"issue":"5","key":"858_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2009.03.017","volume":"137","author":"C Scholl","year":"2009","unstructured":"Scholl C, Fr\u00f6hling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell. 2009;137(5):821\u201334. https:\/\/doi.org\/10.1016\/j.cell.2009.03.017.","journal-title":"Cell"},{"issue":"1","key":"858_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2091-9-25","volume":"9","author":"B Brauksiepe","year":"2008","unstructured":"Brauksiepe B, Mujica AO, Herrmann H, Schmidt ER. The Serine\/threonine kinase Stk33 exhibits autophosphorylation and phosphorylates the intermediate filament protein Vimentin. BMC Biochem. 2008;9(1):25. https:\/\/doi.org\/10.1186\/1471-2091-9-25.","journal-title":"BMC Biochem"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00858-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00858-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00858-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:25:48Z","timestamp":1786929948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00858-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00858-5","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved the Ethics Committee of Xiangya Hospital (Approval number: XY2025091186). All efforts were made to minimize animal suffering and to reduce the number of animals used in the experiments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":3,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"146"}}